Chemotherapy Plus Donor White Blood Cell Infusion in Treating Patients With Relapsed Hematologic Cancer Following Donor Peripheral Stem Cell Transplantation

NCT00005946 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Leukemia
Lymphoma
Multiple Myeloma and Plasma Cell Neoplasm
Myelodysplastic Syndromes

Interventions

BIOLOGICAL: filgrastim
BIOLOGICAL: therapeutic allogeneic lymphocytes
DRUG: cyclophosphamide
DRUG: etoposide

Sponsor

University of Maryland, Baltimore